Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Factors affecting faecal immunochemical test positive rates: demographic, pathological, behavioural and environmental variables.

Symonds EL, Osborne JM, Cole SR, Bampton PA, Fraser RJ, Young GP.

J Med Screen. 2015 May 14. pii: 0969141315584783. [Epub ahead of print]

PMID:
25977374
2.

Effect of intestinal resection on quality of life in Crohn's disease.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.

J Crohns Colitis. 2015 Jun;9(6):452-62. doi: 10.1093/ecco-jcc/jjv058. Epub 2015 Apr 8.

PMID:
25855073
3.

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Leach S, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Day AS, Desmond PV, Gearry RB.

Gastroenterology. 2015 May;148(5):938-947.e1. doi: 10.1053/j.gastro.2015.01.026. Epub 2015 Jan 22.

PMID:
25620670
4.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.

Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S; International Inflammatory Bowel Disease Genetics Consortium; Australia and New Zealand IBDGC; Belgium IBD Genetics Consortium; Italian Group for IBD Genetic Consortium; NIDDK Inflammatory Bowel Disease Genetics Consortium; United Kingdom IBDGC; Wellcome Trust Case Control Consortium; Quebec IBD Genetics Consortium, Daly MJ, Van Steen K, Duerr RH, Barrett JC, McGovern DP, Schumm LP, Traherne JA, Carrington MN, Kosmoliaptsis V, Karlsen TH, Franke A, Rioux JD.

Nat Genet. 2015 Feb;47(2):172-9. doi: 10.1038/ng.3176. Epub 2015 Jan 5.

PMID:
25559196
5.

Colonic motor abnormalities in slow transit constipation defined by high resolution, fibre-optic manometry.

Dinning PG, Wiklendt L, Maslen L, Patton V, Lewis H, Arkwright JW, Wattchow DA, Lubowski DZ, Costa M, Bampton PA.

Neurogastroenterol Motil. 2015 Mar;27(3):379-88. doi: 10.1111/nmo.12502. Epub 2015 Jan 3.

PMID:
25557630
6.

Crohn's disease management after intestinal resection: a randomised trial.

De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.

Lancet. 2015 Apr 11;385(9976):1406-17. doi: 10.1016/S0140-6736(14)61908-5. Epub 2014 Dec 24.

PMID:
25542620
7.

Quantification of in vivo colonic motor patterns in healthy humans before and after a meal revealed by high-resolution fiber-optic manometry.

Dinning PG, Wiklendt L, Maslen L, Gibbins I, Patton V, Arkwright JW, Lubowski DZ, O'Grady G, Bampton PA, Brookes SJ, Costa M.

Neurogastroenterol Motil. 2014 Oct;26(10):1443-57. doi: 10.1111/nmo.12408. Epub 2014 Aug 11.

PMID:
25131177
8.

Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series.

Fazal MW, Doogue MP, Leong RW, Bampton PA, Andrews JM.

BMC Gastroenterol. 2013 Dec 17;13:172. doi: 10.1186/1471-230X-13-172.

9.

Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context.

Bryant RV, Trott MJ, Bennett A, Bampton PA, Moore DJ, Andrews JM.

Intern Med J. 2013 Nov;43(11):1171-6. doi: 10.1111/imj.12272. No abstract available.

PMID:
24237644
10.

Crohn's disease and smoking: is it ever too late to quit?

Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, Radford-Smith G, Croft A, Hanigan K.

J Crohns Colitis. 2013 Dec;7(12):e665-71. doi: 10.1016/j.crohns.2013.05.007. Epub 2013 Jun 20.

PMID:
23790611
11.

High resolution colonic manometry--what have we learnt?--A review of the literature 2012.

Bampton PA, Dinning PG.

Curr Gastroenterol Rep. 2013 Jun;15(6):328. doi: 10.1007/s11894-013-0328-2. Review.

PMID:
23709203
12.

Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program.

Cole SR, Tucker GR, Osborne JM, Byrne SE, Bampton PA, Fraser RJ, Young GP.

Med J Aust. 2013 Apr 1;198(6):327-30.

PMID:
23545032
13.

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, B√ľning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH.

Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582.

14.

Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease.

Kennedy NA, Asser TL, Mountifield RE, Doogue MP, Andrews JM, Bampton PA.

Intern Med J. 2013 Mar;43(3):278-86. doi: 10.1111/j.1445-5994.2012.02936.x.

PMID:
22946880
15.
16.

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH.

J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x.

PMID:
21039834
17.

Non-endoscopic screening for Barrett's oesophagus.

Bampton PA.

BMJ. 2010 Sep 10;341:c4667. doi: 10.1136/bmj.c4667. No abstract available.

PMID:
20833744
18.

Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia.

Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, Sandford J, Morcom J, Bampton PA, Cole SR.

Gastroenterology. 2010 Dec;139(6):1918-26. doi: 10.1053/j.gastro.2010.08.005. Epub 2010 Aug 16.

PMID:
20723544
19.

Anti-tumour necrosis factor-alpha treatment for perianal Crohn's disease in Australia.

Burger DC, Lawrance IC, Bampton PA, Prosser R, Croft A, Gilshenan K, Radford-Smith GL, Florin TH.

Med J Aust. 2010 Apr 5;192(7):375-7.

PMID:
20367582
20.

Un-promoted issues in inflammatory bowel disease: opportunities to optimize care.

Andrews JM, Mountifield RE, Van Langenberg DR, Bampton PA, Holtmann GJ.

Intern Med J. 2010 Mar;40(3):173-82. doi: 10.1111/j.1445-5994.2009.02110.x. Epub 2009 Oct 22. Review.

PMID:
19849744
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk